Back to VA VANGUARD CAPITAL MANAGEMENT LLC
CGEM2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in CULLINAN THERAPEUTICS INC
Yes. Vanguard Capital Management holds 2,614,066 shares of CGEM (Cullinan Therapeutics), worth $47.6M, as of its Q2 2026 13F filing. It increased the position by 131,032 shares (+5.3%) from Q1 2026. Vanguard Capital Management has held CGEM in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$47.6M
Current Shares
2.6M
Total Value Change
+$12.3M
Total Shares Change
+131,032
Quarter-by-Quarter History
Other major holders of CGEM: BlackRock, Inc., BAUPOST GROUP LLC/MA, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP